X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36399) 36399
Book Review (5114) 5114
Newsletter (5080) 5080
Publication (1611) 1611
Newspaper Article (380) 380
Conference Proceeding (352) 352
Magazine Article (323) 323
Book Chapter (192) 192
Dissertation (91) 91
Trade Publication Article (67) 67
Transcript (51) 51
Book / eBook (13) 13
Web Resource (13) 13
Reference (10) 10
Paper (6) 6
Data Set (4) 4
Government Document (4) 4
Presentation (4) 4
Streaming Video (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
warfarin (27722) 27722
index medicus (25448) 25448
humans (24491) 24491
male (12883) 12883
female (12384) 12384
aged (9393) 9393
warfarin - therapeutic use (8700) 8700
anticoagulants - therapeutic use (8526) 8526
middle aged (8468) 8468
atrial fibrillation (7623) 7623
anticoagulants (7618) 7618
stroke (6158) 6158
anticoagulants - adverse effects (5574) 5574
risk factors (5534) 5534
anticoagulants - administration & dosage (5480) 5480
adult (5354) 5354
warfarin - adverse effects (5207) 5207
abridged index medicus (5153) 5153
warfarin - administration & dosage (4971) 4971
cardiac & cardiovascular systems (4867) 4867
research (4312) 4312
anticoagulation (4148) 4148
aged, 80 and over (4046) 4046
prevention (3978) 3978
pharmacology & pharmacy (3867) 3867
medicine, general & internal (3811) 3811
peripheral vascular disease (3795) 3795
atrial fibrillation - drug therapy (3678) 3678
therapy (3588) 3588
hematology (3572) 3572
treatment outcome (3546) 3546
international normalized ratio (3386) 3386
risk (3318) 3318
thromboembolism (3196) 3196
care and treatment (3141) 3141
administration, oral (3058) 3058
dabigatran (3053) 3053
aspirin (2945) 2945
management (2918) 2918
atrial fibrillation - complications (2881) 2881
stroke - prevention & control (2861) 2861
hemorrhage - chemically induced (2752) 2752
drug therapy (2704) 2704
thrombosis (2699) 2699
analysis (2692) 2692
retrospective studies (2620) 2620
atrial-fibrillation (2575) 2575
medical research (2461) 2461
animals (2417) 2417
medicine, experimental (2242) 2242
drug interactions (2141) 2141
surgery (2128) 2128
reports (2122) 2122
time factors (2103) 2103
dosage and administration (2089) 2089
rivaroxaban (2071) 2071
hemorrhage (2051) 2051
warfarin - pharmacology (2044) 2044
health aspects (2010) 2010
thromboembolism - prevention & control (1812) 1812
stroke - etiology (1770) 1770
venous thromboembolism (1763) 1763
mortality (1756) 1756
medicine & public health (1721) 1721
stroke prevention (1717) 1717
follow-up studies (1640) 1640
prospective studies (1629) 1629
patients (1615) 1615
bleeding (1532) 1532
cardiac arrhythmia (1530) 1530
antithrombotic therapy (1511) 1511
prothrombin time (1511) 1511
complications and side effects (1510) 1510
drugs (1502) 1502
aspirin - therapeutic use (1496) 1496
risk assessment (1436) 1436
heparin - therapeutic use (1415) 1415
cardiology (1397) 1397
apixaban (1396) 1396
dose-response relationship, drug (1386) 1386
safety (1383) 1383
pharmacogenetics (1358) 1358
usage (1334) 1334
clinical neurology (1315) 1315
thrombin (1312) 1312
heparin (1297) 1297
oral anticoagulants (1275) 1275
oral anticoagulation (1267) 1267
adolescent (1249) 1249
complications (1245) 1245
blood coagulation - drug effects (1240) 1240
risk-factors (1230) 1230
anticoagulants - pharmacology (1188) 1188
universities and colleges (1153) 1153
vitamin k - antagonists & inhibitors (1146) 1146
drug therapy, combination (1137) 1137
pharmacokinetics (1135) 1135
platelet aggregation inhibitors - therapeutic use (1119) 1119
rats (1113) 1113
clinical trials (1098) 1098
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (39962) 39962
Japanese (507) 507
French (362) 362
German (362) 362
Spanish (342) 342
Russian (211) 211
Chinese (141) 141
Portuguese (105) 105
Czech (96) 96
Italian (91) 91
Swedish (85) 85
Turkish (75) 75
Norwegian (63) 63
Korean (52) 52
Polish (49) 49
Danish (33) 33
Hungarian (26) 26
Finnish (20) 20
Hebrew (18) 18
Slovak (13) 13
Dutch (9) 9
Croatian (7) 7
Persian (6) 6
Serbian (6) 6
Slovenian (5) 5
Bulgarian (4) 4
Afrikaans (3) 3
Romanian (3) 3
Ukrainian (2) 2
Bosnian (1) 1
Georgian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 03/2018, Volume 319, Issue 12, p. 1278
Journal Article
Experimental Hematology, ISSN 0301-472X, 09/2017, Volume 53, pp. S60 - S60
Journal Article
2008, Revisado Agosto de 2008, AHRQ pub., Volume no. 08-0028-B
eBook
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 10/2013, Volume 42, Issue s1, pp. 150 - 151
Journal Article
Clinical Biochemistry, ISSN 0009-9120, 09/2012, Volume 45, Issue 13-14, p. 1119
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 01/2015, Volume 36, Issue 1, p. 7
En cas de changement de molecule d'antivitamine K, la warfarine remplacant la fluindione ou inversement, se pose le probleme de la posologie du nouveau... 
Warfarin
Journal Article
Journal Article
Pharmacy Times, ISSN 0003-0627, 03/2013, Volume 79, Issue 3
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 823 - 833
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin. In a per-protocol, as-treated... 
NON-INFERIORITY | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | DABIGATRAN | STROKE PREVENTION | PHARMACOKINETICS | EFFICACY | ANTITHROMBOTIC THERAPY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | ANTICOAGULATION | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article